FDA
approval
· 2016-04-20
FDA Approved: OXYCONTIN — Supplemental Application (Purdue Pharma LP)
Summary
The FDA approved Purdue Pharma LP's supplemental application for OXYCONTIN (oxycodone hydrochloride), updating labeling as part of the supplemental submission.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OXYCONTIN (OXYCODONE HYDROCHLORIDE)